Although NF1 mutations are risk factors for JMML, the presence of monosomy of chromosome 5, and low levels of fetal hemoglobin (HbF), were more indicative of secondary myelodysplastic/myeloproliferative syndrome (MDS/MPS). This evidence concerns the gene NF1 and juvenile myelomonocytic leukemia.